Comparative study of visual outcome between femtosecond lasik with excimer laser and all femtosecond ReLEx small incision lenticule extraction(SmILE)

ethradhama Superspeciality Eye Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•SINGLE SURGEON
•MYOPIA BETWEEN 1D TO 10D SPHERICAL EQUIVALENT/AMOUNT OF ASTIGMATISM LESS THAN 5D
•AGE ABOVE 21 YEARS AND LESS THAN 40 YEARS.
•STABLE REFRACTION FOR ATLEAST 6MNTHS- 1 YEAR
•SOFT CONTACT LENS DISCONTINUED FOR MINIMUM 1 WEEK AND RIGID GAS PERMEABLE CONTACT LENS DISCONTINUED FOR MINIMUM 3 WEEKS
•CORNEAL TOPOGRAPHY-MINIMUM CORNEAL THICKNESS 480Âµ, RESIDUAL CORNEAL THICKNESS ATLEAST 250Âµ/50% OF ORIGINAL THICKNESS (WHICHEVER IS HIGHER)

•EVIDENCE OF OCULAR DISEASES LIKE MEIBOMIAN GLAND DISEASES, HERPETIC KERATITIS, UVIETIS, GLAUCOMA, VISUALLY SIGNIFICANT CATARACT, RETINAL DISEASES LIKE RETINAL DYSTROPHIES OR DIABETIC RETINOPATHY.
•PROGRESSIVE/UNSTABLE MYOPIA AND/OR ASTIGMATISM
•ANY PATHOLOGIES OF CORNEA LIKE CORNEAL DYSTROPHIES INCLUDING KERATOCONUS,ANY H/O CORNEAL TRAUMA OR SURGERY WITHIN FLAP ZONE
•DRY EYE STATUS-SCHIRMERâ??S 2 TEST VALUE LESS THAN 10 mm
•OCULAR MEDICATION LIKE Î² BLOCKERS.
•TAKING ANY SYSTEMIC MEDICATION LIKELY TO AFFECT WOUND HEALING LIKE CORTICOSTEROIDS OR ANTIMETABOLITES.
•H/O IMMUNOCOMPROMISED STATE OR PREGNANCY OR NURSING MOTHERS

发起方

ethradhama Superspeciality Eye Hospital